Examples of using Data to support in English and their translations into Hungarian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Programming
-
Official/political
-
Computer
Here is some data to support this claim.
Suppliers must deliver the system and provide sufficient data to support such testing.
There are no clinical data to support concomitant treatment of the second eye.
The elderly have a longer elimination half-life andreduced medicinal product clearance as well as limited data to support efficacy in short-term use.
There are no clinical data to support a concomitant treatment of the second eye.
EXUBERA should not be used in patients with lung disease such as asthma and COPD,as there are insufficient data to support the safe use in these patients.
Provide data to support the effectiveness of the antimicrobial preservative at the end of shelf life.
Most of them do not have enough data to support their effectiveness.
There are no data to support the use of antiretroviral drugs other than ZDV as initial therapy.
However, there is very little data to support this prediction.
There are no data to support the co-administration of OLYSIO and telaprevir or boceprevir.
Prepare a thorough and detailed set of documents and financial data to support the claim that a short sale is a good solution for the lender.
Data to support the treatment of genotype 2 infection with Daklinza and sofosbuvir are limited.
Overall, this study did not offer meaningful data to support the clinical efficacy of the approaches studied.
There are no data to support the use of Onduarp in unstable angina pectoris and during or within one month of a myocardial infarction.
Duration of treatment There are insufficient data to support the 100 mg dose for longer than 35 days of treatment.
There are no data to support the use of telmisartan/amlodipine in unstable angina pectoris and during or within one month of a myocardial infarction.
There are no safety, immunogenicity or efficacy data to support interchangeability of Cervarix with other HPV vaccines.
The data to support the use of Pylobactell comes from two main studies of the use of antibiotics to treat H. pylori infection, where it was used as a test.
Hepatic or renal impairment: There are insufficient data to support the use of mitotane in patients with severe hepatic or renal impairment.
There are no clinical data to support the efficacy of sofosbuvir/velpatasvir for the treatment of patients who have failed treatment with a regimen containing another NS5A inhibitor.
In the event that a second dose is to be administered it should be noted that there are no safety,immunogenicity or efficacy data to support interchangeability of Focetria with other H1N1v vaccines.
There are insufficient data to support the 100 mg dose for longer than 35 days of treatment.
Since a second dose is recommended, it should be noted that there are no safety,immunogenicity or efficacy data to support interchangeability of Prepandemic Influenza vaccine(H5N1)(surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics with other H5N1 monovalent vaccines.
There are insufficient data to support the use of mitotane in patients with severe hepatic or renal impairment.
There are no clinical data to support the concomitant treatment with theophylline for maintenance therapy.
There are no clinical study data to support the clinical safety of Diacomit administered at daily doses greater than 50mg/ kg/ day.
Scientific research provides compelling data to support the anecdotal evidence that giving is a powerful pathway to personal growth and lasting happiness.
Similarly, there are presently no data to support the effectiveness of NS3/4A protease inhibitors in patients who previously failed prior therapy that included an NS3/4A protease inhibitor.
There are no safety, immunogenicity or efficacy data to support change during vaccination with Silgard to other HPV vaccines which do not cover the same HPV types.